HYLA, a portmanteau of HYdrogen and NikoLA, is a Nikola-owned subsidiary that is focusing on building a "robust hydrogen supply chain." HYLA's first station can refill a typical commercial truck ...

Inspira Technologies' innovative blood sensor is gaining attention. According to a recent announcement, results from the ...

PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) ...

Inspira Technologies (IINN) announced positive results from the clinical study of its AI-powered HYLA blood sensor. The HYLA achieved 96% ...

Inspira Technologies develops its innovative AI-powered HYLA technology with advanced blood testing capability, enabling continuous monitoring of tissue oxygenation and early hypoxia detection ...

Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced positive results from the clinical ...

The Company is proud to report that the HYLA successfully achieved 96% accuracy in its clinical study results for a key parameter, as compared to traditional blood test analyzers. In addition ...

Inspira Technologies' HYLA blood sensor achieves 96% accuracy in clinical study, paving the way for FDA submission by 2025.

The clinical study involved 6 patients undergoing open-heart surgery with the clip-on HYLA blood sensor attached at two different points on the blood circuit tubing, allowing monitoring of the ...